Elicio Therapeutics (ELTX) Net Cash Flow (QoQ) (2020 - 2026)
Elicio Therapeutics (ELTX) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Elicio Therapeutics |
70.12 Mn |
55.17 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-85.54% |
| Dec 31, 2025 |
-28.80% |
| Sep 30, 2025 |
-150.77% |
| Jun 30, 2025 |
1,326.79% |
| Mar 31, 2025 |
102.44% |
| Dec 31, 2024 |
-136.47% |
| Sep 30, 2024 |
371.32% |
| Jun 30, 2024 |
-690.32% |
| Mar 31, 2024 |
62.16% |
| Dec 31, 2023 |
44.02% |
| Sep 30, 2023 |
-142.84% |
| Jun 30, 2023 |
540.50% |
| Mar 31, 2023 |
-50.49% |
| Dec 31, 2022 |
12.14% |
| Sep 30, 2022 |
-50.38% |
| Jun 30, 2022 |
143.65% |
| Mar 31, 2022 |
-11.96% |
| Dec 31, 2021 |
3.89% |
| Sep 30, 2021 |
-10.72% |
| Jun 30, 2021 |
-113.72% |
